A case report of renal pelvis carcinoma
Yan-You Li1, Xiao-Long Li1, Zhi-Long Dong2
1Second School of Clinical Medicine, University of Lanzhou Lanzhou 730000, Gansu, China.
Abstract:
Urothelial carcinoma (UC) is a common type of carcinoma worldwide, and it is rare to find it metastasize to the brain. Antibody-drug conjugates (ADCs) are an emerging treatment for patients. Our department treated a patient with Urothelial carcinoma (UC) that metastazied to the brain with Disitamab Vedotin. Therefore, the aim of this article is to review and share this rare carcinoma case treated in our department, and to have a deep understanding of Antibody-drug conjugates (ADCs) so that we can improve treatment for Urothelial carcinoma (UC). Informed consent was granted by the patient to share the case information.
More Related Videos
06:39Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Published on: November 22, 2019
03:19Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
Published on: June 21, 2024
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Imaging Studies II: Ultrasonography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
